664. Increase in the Occurrence of Carbapenem-Resistant Enterobacterales (CRE) in United States (US) Hospitals from 2019 to 2021 and Activity of Novel b-Lactam/b-Lactamase Inhibitor (BL/BLI) Combinations Against These Isolates

BACKGROUND: CRE isolates are considered a threat to human health. Until recently, the treatment options for CRE were limited. New BL/BLIs, such as ceftazidime-avibactam (CAZ-AVI), meropenem-vaborbactam (MVB), and imipenem-relebactam (IMI-REL), are active against most of these isolates, but these age...

Descripción completa

Detalles Bibliográficos
Autores principales: Castanheira, Mariana, Doyle, Timothy, Kantro, Valerie, Mendes, Rodrigo E, Sader, Helio S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751949/
http://dx.doi.org/10.1093/ofid/ofac492.716

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751949/
http://dx.doi.org/10.1093/ofid/ofac492.716

Ejemplares similares